Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial

James L. Gulley(Center for Cancer Research), Arun Rajan(National Institutes of Health), David R. Spigel(Sarah Cannon), Nicholas Iannotti(Hematology Oncology Associates), Jason C. Chandler(West Cancer Center), Deborah Jean Lee Wong(University of California, Los Angeles), Joseph W. Leach, W. Jeff Edenfield, Ding Wang(Henry Ford Hospital), H. Grote(Merck (Germany)), Anja von Heydebreck(Merck (Germany)), Kevin M. Chin(Ono Pharmaceutical (United States)), Jean-Marie Cuillerot(Ono Pharmaceutical (United States)), Karen Kelly(UC Davis Comprehensive Cancer Center)
The Lancet Oncology
March 31, 2017
10.1016/s1470-2045(17)30240-1
Cited by 284Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis